Ignite Creation Date:
2025-12-24 @ 11:30 PM
Ignite Modification Date:
2026-01-05 @ 5:29 PM
Study NCT ID:
NCT02926456
Status:
COMPLETED
Last Update Posted:
2018-04-24
First Post:
2016-09-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study in HIV1-Positive, Virosuppressed Patients Currently inTreatment With Ritonavir-Boosted Protease Inhibitors (PI/r) Starting Cobicistat-Boosted Darunavir (DRV/c - Rezolsta)
Sponsor:
Janssen-Cilag S.p.A.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-07-22
Start Date Type:
ACTUAL
Primary Completion Date:
2018-02-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-02-14
Completion Date Type:
ACTUAL
First Submit Date:
2016-09-21
First Submit QC Date:
None
Study First Post Date:
2016-10-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-04-23
Last Update Post Date:
2018-04-24
Last Update Post Date Type:
ACTUAL